Structure | PrIMAVeRa

Publications

This is a list of publications related to the work of the PrIMAVeRa Consortium published in scientific journals. Please contact the Project Leader for more information, or if a relevant publication is missing: irina.meln@euvaccine.eu

Global burden of antimicrobial resistance: essential pieces of a global puzzle

Author(s): Marlieke E A de Kraker, Stephan Harbarth
Published in: The Lancet, Volume 399, Issue 10344, P2347, June 25, 2022.
DOI: 10.1016/s0140-6736(22)00940-0

Estimating antimicrobial resistance burden in Europe—what are the next steps?

Author(s): Nasreen Hassoun-Kheir, Stephan Harbarth
Published in: The Lancet Public Health, Volume 7, Issue 11, E886-E887, November 01, 2022.
DOI: 10.1016/s2468-2667(22)00250-x

Synthesizing pathogen- and infection-specific estimates of the burden of antimicrobial resistance in Europe for health-technology assessment: gaps, heterogeneity, and bias

Author(s): J. Robotham, E. Tacconelli, V. Vella, M. de Kraker.

Published in: Clinical Microbiology and Infection, 30, S1–S3. March 2024.

DOI: https://doi.org/10.1016/j.cmi.2023.10.004

Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review

Author(s): M. Pezzani, F. Arieti, N. Rajendran, B. Barana, E. Cappelli, M. De Rui, L. Galia, Na. Hassoun-Kheir, L. Argante, J. Schmidt, J. Rodriguez-Bano, S. Harbarth, M. de Kraker, B. Gladstone, E. Tacconelli.

Published in: Clinical Microbiology and Infection, Volume 30, S 1, Pages S4-S13. March 2024.

Publisher: Elsevier

DOI: https://doi.org/10.1016/j.cmi.2023.10.019

Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis

Author(s): R. Kingston, V. Vella, K. Pouwels, J. Schmidt, R. El-Abasiri, E. Reyna-Villasmil, N. Hassoun-Kheir, S. Harbarth, J. Rodriguez-Baño, E. Tacconelli, F. Arieti, B. Gladstone, M. de Kraker, N. Naylor, J. Robotham on behalf of PrIMAVeRa Workpackage 1: B. Barana, E. Cappelli, M. De Rui, R. El-Abasiri, L. Galia, J. Geurtsen, J. Mejia, A. Palladino, A. Piljic, N. Babu Rajendran, E. Reyna-Villasmil, J. Schmidt.

Published in: Clinical Microbiology and Infection, 30, S26–S36. March 2024.

DOI: https://doi.org/10.1016/j.cmi.2023.12.013

Using contact network dynamics to implement efficient interventions against pathogen spread in hospital settings: A modelling study.

Author(s): Q. Leclerc, A. Duval D. Guillemot, L. Opatowski, L. Temime.

Published in: PLoS Medicine. July 2024.

DOI: https://doi.org/10.1371/journal.pmed.1004433

Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodies

Author(s): Hassoun-Kheir Nasreen, Guedes Mariana, Arieti Fabiana, Pezzani Maria Diletta, Gladstone Beryl Primrose, Robotham Julie V, Pouwels Koen B, Kingston Rhys, Carmeli Yehuda, Cassini Alessandro, Cecchini Michele, Drobniewski Francis, Frost Isabel, Geurtsen Jeroen, Kronenberg Andreas, Htay Mila Nu Nu, Paul Mical, Rocha-Pereira Nuno, Rodríguez-Baño Jesús, Scudeller Luigia, Stewardson Andrew J, Tacconelli Evelina, Harbarth Stephan, Vella Venanzio, de Kraker Marlieke EA.

Published in: Euro Surveillance. October 2024.

DOI: https://doi.org/10.2807/1560-7917.ES.2024.29.47.2400212

A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe

Author(s): Nasreen Hassoun-Kheir, Mariana Guedes, Marie-Therese Ngo Nsoga, Lorenzo Argante, Fabiana Arieti, Beryl P. Gladstone, Rhys Kingston, Nichola R. Naylor, Maria D. Pezzani, Koen B. Pouwels, Julie V. Robotham, Jesús Rodríguez-Baño, Evelina Tacconelli, Venanzio Vella, Stephan Harbarth, Marlieke E.A. de Kraker, on behalf of PrIMAVeRa Workpackage 1.

Published in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 30 Suppl 1, Mar 2024

DOI: 10.1016/j.cmi.2023.09.001

The AMR Accelerator: from individual organizations to efficient antibiotic development partnerships

Author(s): Josepine Fernow, Marie Olliver, William Couet, Sophie Lagrange, Meindert H Lamers, Ole F Olesen, Kristina Orrling, Michel Pieren, Derek J Sloan, Juan José Vaquero, Timothy J Miles, Anders Karlén

Published in: Nature reviews. Drug discovery, 10.1038/d41573-024-00138-9. 23 Sep. 2024

DOI: https://doi.org/10.1038/d41573-024-00138-9

How to: share and reuse data—challenges and solutions from predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance project

Author(s): Mariana Guedes, Almudena de la Serna Bazan, Elena Rubio-Martín, Lydia Barrera Pulido, Virginia Palomo, Alen Piljić , Quentin J. Leclerc, Emmanuel Aris, Venanzio Vella, Asta Dambrauskienė, Julie V. Robotham, Astrid Pérez, Nasreen Hassoun-Kheir, Marlieke E.A. de Kraker, Fabiana Arieti, Ruth Joanna Davis, Evelina Tacconelli, Elena Salamanca-Rivera, Jesús Rodríguez-Baño

Published in: Clinical microbiology and infection, S1198-743X(25)00031-X. 25 Jan. 2025

DOI: https://doi.org/10.1016/j.cmi.2025.01.024

Targeted mupirocin-based decolonization for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients - a longitudinal study over 20 years.

Author(s): Hassoun-Kheir, N., Buetti, N., Olivier, V., Perez, M., Frossard, J., Renzi, G., Schrenzel, J., Saudan, P., Harbarth, S.

Published in: The Journal of hospital infection vol. 135 (2023): 55-58.

DOI: https://doi.org/10.1016/j.jhin.2023.01.019

Publications

Privacy Policy | Disclaimer | Contact us | Back to top